EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Value of ER∝ in the Prognosis of GH- and PRL-Secreting PitNETs: Clinicopathological Correlations

Roxana-Ioana Dumitriu-Stan iD, Iulia-Florentina Burcea, Valeria Nicoleta Nastase, Raluca Amalia Ceaușu iD, Anda Dumitrascu, Laurentiu Catalin Cocosila, Alexandra Bastian, Sabina Zurac, Marius Raica, Catalina Poiana

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms242216162 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Roxana-Ioana Dumitriu-Stan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, 'Carol Davila' University of Medicine and Pharmacy, 020021 Bucharest, Romania. Hauptthemen laut MEDLINE: Adenoma, Pituitary Neoplasms, Prolactinoma, Neuroendocrine Tumors. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: “Carol Davila” University of Medicine and Pharmacy Bucharest.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pituitary neuroendocrine tumors (PitNETs) are divided into multiple histological subtypes, which determine their clinical and biological variable behavior. Despite their benign evolution, in some cases, prolactin (PRL) and growth hormone (GH)-secreting PitNETs may have aggressive behavior. In this study, we investigated the potential predictive role of ER∝, alongside the clinicopathological classification of PitNETs (tumor diameter, tumor type, and tumor grade). A retrospective study was conducted with 32 consecutive cases of PRL- and mixed GH- and PRL-secreting PitNETs (5 patients with prolactinomas and 27 with acromegaly, among them, 7 patients with GH- and PRL- co-secretion) who underwent transsphenoidal intervention. Tumor specimens were histologically and immunohistochemical examined: anterior pituitary hormones, ki-67 labeling index, CAM 5.2, and ER∝; ER∝ expression was correlated with basal PRL levels at diagnosis (rho = 0.60, p < 0.01) and postoperative PRL levels (rho = 0.58, p < 0.001). In our study, the ER∝ intensity score was lower in female patients. Postoperative maximal tumor diameter correlated with Knosp grade (p = 0.02); CAM 5.2 pattern (densely/sparsely granulated/mixed densely and sparsely granulated) was correlated with postoperative PRL level (p = 0.002), and with ki-67 (p < 0.001). The IGF1 level at diagnosis was correlated with the postoperative GH nadir value in the oral glucose tolerance test (OGTT) (rho = 0.52, p < 0.05). Also, basal PRL level at diagnosis was correlated with postoperative tumor diameter (p = 0.63, p < 0.001). At univariate logistic regression, GH nadir in OGTT test at diagnostic, IGF1, gender, and invasion were independent predictors of remission for mixed GH- and PRL-secreting Pit-NETs; ER∝ can be used as a prognostic marker and loss of ER∝ expression should be considered a sign of lower differentiation and a likely indicator of poor prognosis. A sex-related difference can be considered in the evolution and prognosis of these tumors, but further studies are needed to confirm this hypothesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenomaPituitary NeoplasmsProlactinomaNeuroendocrine TumorsHumansFemaleRetrospective StudiesKi-67 AntigenProlactin

Stichwörter der Autor:innen

GH- and PRL-secreting PitNETPRL-secreting PitNETestrogen receptor alphapituitary neuroendocrine tumorprognostic factors

Substanzen

Ki-67 AntigenProlactin

Autor:innen und Institutionen

  • Department of Endocrinology, 'Carol Davila' University of Medicine and Pharmacy, 020021 Bucharest, Romania.
  • 'C. I. Parhon' National Institute of Endocrinology, 011863 Bucharest, Romania.
  • Department of Microscopic Morphology/Histology, 'Victor Babes' University of Medicine and Pharmacy, 300041 Timisoara, Romania.
  • Angiogenesis Research Centre, 'Victor Babes' University of Medicine and Pharmacy, 300041 Timisoara, Romania.
  • 'Bagdasar-Arseni' Emergency Hospital, 041915 Bucharest, Romania.
  • Department of Pathology, Colentina Clinical Hospital, 020125 Bucharest, Romania.

ORCID-Profile: Roxana-Ioana Dumitriu-Stan, Raluca Amalia Ceaușu

Förderung

  • “Carol Davila” University of Medicine and Pharmacy Bucharest

Zitieren

APA

Dumitriu-Stan, R. I., Burcea, I. F., Nastase, V. N., Ceaușu, R. A., Dumitrascu, A., Cocosila, L. C., Bastian, A., Zurac, S., Raica, M., & Poiana, C. (2023). The Value of ER∝ in the Prognosis of GH- and PRL-Secreting PitNETs: Clinicopathological Correlations. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242216162

Vancouver

Dumitriu-Stan RI, Burcea IF, Nastase VN, Ceaușu RA, Dumitrascu A, Cocosila LC, et al. The Value of ER∝ in the Prognosis of GH- and PRL-Secreting PitNETs: Clinicopathological Correlations. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242216162

BibTeX
@article{DumitriuStan2023,
  author = {Dumitriu-Stan, Roxana-Ioana and Burcea, Iulia-Florentina and Nastase, Valeria Nicoleta and Ceaușu, Raluca Amalia and Dumitrascu, Anda and Cocosila, Laurentiu Catalin and Bastian, Alexandra and Zurac, Sabina and Raica, Marius and Poiana, Catalina},
  title = {The Value of ER∝ in the Prognosis of GH- and PRL-Secreting PitNETs: Clinicopathological Correlations},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms242216162}
}
Kostenlos starten →